Cart
sales@molnova.com
Home - Products - Apoptosis - TNF - Homovanillyl alcohol

Homovanillyl alcohol

CAS No. 2380-78-1

Homovanillyl alcohol( —— )

Catalog No. M24097 CAS No. 2380-78-1

Homovanillyl alcohol is a biological metabolite of Hydroxytyrosol.?

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 35 In Stock
200MG 50 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Homovanillyl alcohol
  • Note
    Research use only, not for human use.
  • Brief Description
    Homovanillyl alcohol is a biological metabolite of Hydroxytyrosol.?
  • Description
    Homovanillyl alcohol is a biological metabolite of Hydroxytyrosol.?Hydroxytyrosol is a phenolic compound that is present in virgin olive oil (VOO) and wine.?Homovanillyl alcohol displays high scavenging activities, it protects red blood cells from hemolysis in a dose-dependent manner.?Homovanillyl alcohol has protective effect on cardiovascular disease and total mortality.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    TNF
  • Recptor
    TNF-α
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2380-78-1
  • Formula Weight
    168.19
  • Molecular Formula
    C9H12O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    OCCC1=CC=C(O)C(OC)=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Olive oil phenolic compounds inhibit homocysteine-induced endothelial cell adhesion regardless of their different antioxidant activity.J Agric Food Chem. 2009 May 13;57(9):3478-82
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Certolizumab pegol

    Certolizumab pegol (Certolizumab) is a polyethylene glycolated and humanized anti-TNF-α monoclonal antibody for the study of autoimmune diseases such as rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA).

  • SPD304

    SPD304 is a selective TNF-α inhibitor and blocks the interaction of TNF and its receptor. SPD304 has an IC50 of 22 μM for inhibiting in vitro TNF receptor 1 binding to TNF-α.

  • GSK3145095

    GSK3145095 is an orally active inhibitor of RIPK1 with IC50 of 5 nM, with potential immunomodulatory activities and antineoplastic.

Sign In Join Free